Early safety and efficacy of percutaneous left atrial appendage suture ligation: Results from the U.S. Transcatheter LAA ligation consortium

Journal of the American College of Cardiology

Volumn 64, Issue 6, 2014, Pages 565-572

  Price, Matthew J ^a   Gibson, Douglas N ^a   Yakubov, Steven J ^b   Schultz, Jason C ^a   Di Biase, Luigi ^c   Natale, Andrea ^c   Burkhardt, J David ^c   Pershad, Ashish ^d   Byrne, Timothy J ^d   Gidney, Brett ^e   Aragon, Joseph R ^f   Goldstein, Jeffrey ^g   Moulton, Kriegh ^g   Patel, Taral ^h   Knight, Bradley ^h   Lin, Albert C ^h   Valderrábano, Miguel ⁱ  

^a SCRIPPS CLINIC   (United States)

^b RIVERSIDE METHODIST HOSPITAL   (United States)

^c TEXAS CARDIAC ARRHYTHMIA INSTITUTE   (United States)

^d BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^e Heart Rhythm Center   (United States)

^f Samsun Clinic   (United States)

^g Prairie Heart Institute   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

atrial fibrillation; Lariat; left atrial appendage; stroke

Indexed keywords

ATRIAL FIBRILLATION; LARIAT; LEFT ATRIAL APPENDAGE; STROKE;

AGED; AGED, 80 AND OVER; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CARDIAC CATHETERIZATION; CARDIAC SURGICAL PROCEDURES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIGATION; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84905701209     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.03.057     Document Type: Article

References (26)

1. L.S. Wann, A.B. Curtis, and C.T. January et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 57 2011 223 242
2. J.L. Blackshear, and J.A. Odell Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation Ann Thorac Surg 61 1996 755 759
3. M.R. Patel, K.W. Mahaffey, J. Garg for the ROCKET AF Investigators Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
4. S.J. Connolly, M.D. Ezekowitz, S. Yusuf and the RE-LY Steering Committee and Investigators Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
5. C.B. Granger, J.H. Alexander, J.J. McMurray for the ARISTOTLE Committees and Investigators Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
6. R.P. Giugliano, C.T. Ruff, E. Braunwald for the ENGAGE AF-TIMI 48 Investigators Edoxaban versus warfarin in patients with atrial fibrillation N Engl J Med 369 2013 2093 2104
7. S.J. Connolly, J. Eikelboom, C. Joyner for the AVERROES Steering Committee and Investigators Apixaban in patients with atrial fibrillation N Engl J Med 364 2011 806 817
8. V. Fuster, L.E. Rydén, and D.S. Cannom et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 57 2011 e101 e198
9. D.R. Holmes, V.Y. Reddy, Z.G. Turi for the PROTECT AF Investigators Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial Lancet 374 2009 534 542
10. V.Y. Reddy, S.K. Doshi, and H. Sievert et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial Circulation 127 2013 720 729
11. B. Plicht, T.F. Konorza, and P. Kahlert et al. Risk factors for thrombus formation on the Amplatzer Cardiac Plug after left atrial appendage occlusion J Am Coll Cardiol Intv 6 2013 606 613
12. A. Sepahpour, M.K. Ng, P. Storey, and M.A. McGuire Death from pulmonary artery erosion complicating implantation of percutaneous left atrial appendage occlusion device Heart Rhythm 10 2013 1810 1811
13. M. Gasparini, C. Ceriotti, and R. Bragato Huge left atrial thrombus after left atrial appendage occlusion with a Watchman device Eur Heart J 33 2012 1998
14. K. Bartus, F.T. Han, and J. Bednarek et al. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience J Am Coll Cardiol 62 2013 108 118
15. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation Chest 137 2010 263 272
16. G.Y. Lip, L. Frison, J.L. Halperin, and D.A. Lane Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score J Am Coll Cardiol 57 2011 173 180
17. R. Mehran, S.V. Rao, and D.L. Bhatt et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation 123 2011 2736 2747
18. D. Stone, T. Byrne, and A. Pershad Early results with the LARIAT device for left atrial appendage exclusion in patients with atrial fibrillation at high risk for stroke and anticoagulation Catheter Cardiovasc Interv 2013 Jun 13 [E-pub ahead of print]
19. V.Y. Reddy, D. Holmes, S.K. Doshi, P. Neuzil, and S. Kar Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry Circulation 123 2011 417 424
20. J.F. Viles-Gonzalez, S. Kar, and P. Douglas et al. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy J Am Coll Cardiol 59 2012 923 929
21. A.S. Kanderian, A.M. Gillinov, G.B. Pettersson, E. Blackstone, and A.L. Klein Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography J Am Coll Cardiol 52 2008 924 929
22. W.J. Mosley 2nd, M.R. Smith, and M.J. Price Percutaneous management of late leak after Lariat transcatheter ligation of the left atrial appendage in patients with atrial fibrillation at high risk for stroke Catheter Cardiovasc Interv 83 2014 664 669
23. W.L. Yeow, T. Matsumoto, and S. Kar Successful closure of residual leak following LARIAT procedure in a patient with high risk of stroke and hemorrhage Catheter Cardiovasc Interv 2013 Oct 2 [E-pub ahead of print]
24. G. Ailawadi, M.W. Gerdisch, and R.L. Harvey et al. Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial J Thorac Cardiovasc Surg 142 2011 1002 1009
25. D.F. Briceno, R.R. Fernando, and S.T. Laing Left atrial appendage thrombus post LARIAT closure device Heart Rhythm 2013 Nov 1 [E-pub ahead of print]
26. M.S. Baker, J. Paul Mounsey, A.K. Gehi, and E.H. Chung Left atrial thrombus after appendage ligation with LARIAT Heart Rhythm 11 2014 1489